WBR0795
| Author | [[PageAuthor::Rim Halaby, M.D. [1]]] |
|---|---|
| Exam Type | ExamType::USMLE Step 1 |
| Main Category | MainCategory::Pharmacology |
| Sub Category | SubCategory::Cardiology |
| Prompt | [[Prompt::A 62 year old man with atrial fibrillation is admitted to the hospital for cardioversion. During his hospital stay the patient suddenly develops severe dizziness and loses consciousness on his way to the bathroom. An EKG strip from the cardiac monitor is shown below. Which of the following medication could be responsible for the patient's condition? |
| Answer A | AnswerA::Metoprolol |
| Answer A Explanation | AnswerAExp::Metoprolol doesn't affect the QT interval. It does not increase the risk for torsades des pointes. |
| Answer B | AnswerB::Lidocaine |
| Answer B Explanation | AnswerBExp::Lidocaine doesn't affect the QT interval. It does not increase the risk for torsades des pointes. |
| Answer C | AnswerC::Propafenone |
| Answer C Explanation | AnswerCExp::Propafenone doesn't affect the QT interval. It does not increase the risk for torsades des pointes. |
| Answer D | AnswerD::Dofetilide |
| Answer D Explanation | AnswerDExp::defetilide is a Class III antiarrhythmic used for cardoversion. It prolongs the QT interval and leads to torsades des pointes. |
| Answer E | AnswerE::Mexiletine |
| Answer E Explanation | AnswerEExp::Mexiletine doesn't affect the QT interval. It does not increase the risk for torsades des pointes. |
| Right Answer | RightAnswer::D |
| Explanation | [[Explanation::Torsades des pointes is a ventricular tachycardia characterized by polymorphic wave forms with typical crescendo-decrescendo pattern about the isoelectric line. Torsades des pointes is a complication of prolonged QT interval that can progress to ventricular fibrillation and sudden death. Many medications can lead to torsades des pointes, but the classical drugs associated with QT prolongation include Class IA and Class III antiarrhythmics (except amiodarone). Dofetilide is a class III antiarrhythmic used in the treatment of atrial fibrillation for the restoration of regular rhythm. It is a complication that can be seen in up to 10% of patients in certain studies often indicating the need for hospitalization and close monitoring.
Viskin S. Long QT syndromes and torsade de pointes. The Lancet. 1999;354(9190):1625-1633. |
| Approved | Approved::No |
| Keyword | WBRKeyword::Dofetilide, WBRKeyword::Torsades des pointes, WBRKeyword::QT prolongation |
| Linked Question | Linked:: |
| Order in Linked Questions | LinkedOrder:: |
